| | |
| Clinical data | |
|---|---|
| Other names | 4,5-Methylenedioxy-N,N-dimethyltryptamine |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | Unknown [1] |
| Duration of action | Unknown [1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H16N2O2 |
| Molar mass | 232.283 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 93 to 95 °C (199 to 203 °F) [2] |
| |
| |
| | |
4,5-MDO-DMT, or 4,5-methylenedioxy-N,N-dimethyltryptamine, is a lesser-known psychedelic drug of the tryptamine family. [1] It is the 4,5-methylenedioxy derivative of dimethyltryptamine (DMT) and is an analogue of psilocin (4-HO-DMT) and 5-MeO-DMT. [1] The drug was included as an entry in Alexander Shulgin's 1997 book TiHKAL (Tryptamines I Have Known and Loved), but it was not tested to determine its psychoactive effects and its dose and duration are unknown. [1] Studies in rodents found that its potential hallucinogenic potency is less than that of 4,5-MDO-DiPT but greater than that of 5,6-MDO-DiPT. [2] 4,5-MDO-DMT was first described in the scientific literature by Toni B. Kline and colleagues in 1982. [2]
| Tryptamines |
|
|---|---|
| 4-Hydroxytryptamines and esters/ethers |
|
| 5-Hydroxy- and 5-methoxytryptamines |
|
| N-Acetyltryptamines |
|
| α-Alkyltryptamines |
|
| Cyclized tryptamines |
|
| Isotryptamines | |
| Related compounds |
|
| | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |